Detection reagents and kit for identifying oxidized state and glycated state of low-density lipoproteins

US11725002B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11725002-B2
Application numberUS-201816609028-A
CountryUS
Kind codeB2
Filing dateApr 27, 2018
Priority dateApr 28, 2017
Publication dateAug 15, 2023
Grant dateAug 15, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A detection reagent for comprehensively detecting an oxidized state and a glycated state of a low-density lipoprotein. While an oxidized low-density lipoprotein and a glycated low-density lipoprotein are detected with a fluolophore-labelled antibody, a lipid radical is detected with a fluorescent nitroxide 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD-Pen).

First claim

Opening claim text (preview).

The invention claimed is: 1. A detection reagent containing a primary detection antibody recognizing an oxidized low-density lipoprotein, a primary detection antibody recognizing a glycated low-density lipoprotein, a secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein, a secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein, wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing glycated low-density lipoprotein are fluorescently labelled with fluorophores, and a fluorescent nitroxide represented by the chemical structure (1): 2. The detection reagent according to claim 1 , wherein the primary detection antibody recognizing the oxidized low-density lipoprotein is a mixture containing at least an antibody recognizing malondialdehyde lysine, an antibody recognizing 4-hydroxy-2-nonenal lysine, and an antibody recognizing acrolein lysine. 3. The detection reagent according to claim 1 , wherein the primary detection antibody recognizing the glycated low-density lipoprotein is a mixture containing at least an antibody recognizing pentosidin, an antibody recognizing crossline, an antibody recognizing (Nε-carboxymethyl)lysine, an antibody recognizing (Nε-carboxyethyl)lysine, and an antibody recognizing pyrraline. 4. A kit for identifying an oxidized state and a glycated state of a low-density lipoprotein, which includes a microplate on which an antibody recognizing a low-density lipoprotein is immobilized, and the detection reagent according to claim 1 . 5. The kit according to claim 4 , wherein at least one of the fluorophores is a 7-nitrobenzofurazan derivative. 6. The kit according to claim 4 , wherein the fluorophores have emission wavelengths different from each other. 7. The kit according to claim 4 , wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein are each fluorescently labelled with a fluorophore which is excited with an excitation wavelength of 485 nm and observed fluorescent intensity at 528 nm. 8. The detection reagent according to claim 1 , wherein the fluorophores have emission wavelengths different from each other. 9. The detection reagent according to claim 1 , wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein are each fluorescently labelled with a fluorophore which can be excited with an excitation wavelength at 485 nm and observed fluorescent intensity at 528 nm.

Assignees

Inventors

Classifications

  • C07D413/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • against material from animals or humans · CPC title

  • Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title

  • producing a change of colour · CPC title

  • with fluorescent label · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11725002B2 cover?
A detection reagent for comprehensively detecting an oxidized state and a glycated state of a low-density lipoprotein. While an oxidized low-density lipoprotein and a glycated low-density lipoprotein are detected with a fluolophore-labelled antibody, a lipid radical is detected with a fluorescent nitroxide 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD…
Who is the assignee on this patent?
Fuso Pharmaceutical Ind, Yamada Ken Ichi
What technology area does this patent fall under?
Primary CPC classification C07D413/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).